Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
CRISPR/Cas9 genome editing in human pluripotent stem cells: Harnessing human genetics in a dish.

Developmental dynamics : an official publication of the American Association of Anatomists

González F.
PMID: 27145095
Dev Dyn. 2016 Jul;245(7):788-806. doi: 10.1002/dvdy.24414. Epub 2016 Jun 09.

Because of their extraordinary differentiation potential, human pluripotent stem cells (hPSCs) can differentiate into virtually any cell type of the human body, providing a powerful platform not only for generating relevant cell types useful for cell replacement therapies, but...

Induced pluripotent stem cells as a next-generation biomedical interface.

Laboratory investigation; a journal of technical methods and pathology

Hankowski KE, Hamazaki T, Umezawa A, Terada N.
PMID: 21555998
Lab Invest. 2011 Jul;91(7):972-7. doi: 10.1038/labinvest.2011.85. Epub 2011 May 09.

Recent advances in DNA sequencing technologies and subsequent progress in genome-wide association study (GWAS) are rapidly changing the landscape of human diseases. Our knowledge on disease-gene linkage has been exponentially growing, and soon we will obtain complete maps of...

Genome Editing in Human Neural Stem and Progenitor Cells.

Results and problems in cell differentiation

Bressan RB, Pollard SM.
PMID: 30209659
Results Probl Cell Differ. 2018;66:163-182. doi: 10.1007/978-3-319-93485-3_7.

Experimental tools for precise manipulation of mammalian genomes enable reverse genetic approaches to explore biology and disease. Powerful genome editing technologies built upon designer nucleases, such as CRISPR/Cas9, have recently emerged. Parallel progress has been made in methodologies for...

Gene correction in human embryonic and induced pluripotent stem cells: promises and challenges ahead.

Molecular therapy : the journal of the American Society of Gene Therapy

Narsinh KH, Wu JC.
PMID: 20514030
Mol Ther. 2010 Jun;18(6):1061-3. doi: 10.1038/mt.2010.92.

No abstract available.

Array-comparative genomic hybridization characterization of human pluripotent stem cells.

Methods in molecular biology (Clifton, N.J.)

Elliott AM, Elliott KA, Kammesheidt A.
PMID: 22528361
Methods Mol Biol. 2012;873:261-7. doi: 10.1007/978-1-61779-794-1_17.

During culture adaptation, human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) tend to acquire chromosomal aberrations. Generally, stem cell lines are screened for large-scale chromosomal changes using low resolution karyotype analysis. Recent studies characterizing human stem...

Improving single-cell cloning workflow for gene editing in human pluripotent stem cells.

Stem cell research

Chen YH, Pruett-Miller SM.
PMID: 30099335
Stem Cell Res. 2018 Aug;31:186-192. doi: 10.1016/j.scr.2018.08.003. Epub 2018 Aug 04.

The availability of human pluripotent stem cells (hPSCs) and progress in genome engineering technology have altered the way we approach scientific research and drug development screens. Unfortunately, the procedures for genome editing of hPSCs often subject cells to harsh...

The transcriptome of human pluripotent stem cells.

Current opinion in genetics & development

Au KF, Sebastiano V.
PMID: 25461453
Curr Opin Genet Dev. 2014 Oct;28:71-7. doi: 10.1016/j.gde.2014.09.012. Epub 2014 Oct 27.

Human Embryonic Stem Cells (hESCs) are in vitro derivatives of the inner cell mass of the blastocyst and are characterized by an undifferentiated and pluripotent state that can be perpetuated in time, indefinitely. hESCs provide a unique opportunity to...

Profiling of naïve and primed human pluripotent stem cells reveals state-associated miRNAs.

Scientific reports

Dodsworth BT, Hatje K, Rostovskaya M, Flynn R, Meyer CA, Cowley SA.
PMID: 32601281
Sci Rep. 2020 Jun 29;10(1):10542. doi: 10.1038/s41598-020-67376-w.

Naïve human pluripotent stem cells (hPSC) resemble the embryonic epiblast at an earlier time-point in development than conventional, 'primed' hPSC. We present a comprehensive miRNA profiling of naïve-to-primed transition in hPSC, a process recapitulating aspects of early in vivo...

Showing 1 to 8 of 8 entries